01 3Belmore Neidrauer LLP
02 2Blake Cassels & Graydon LLP
03 49Gilead Sciences Canada Inc.
01 22075189
02 12101572
03 22104399
04 22105486
05 42261619
06 12279198
07 42298059
08 22398887
09 62416757
10 22452217
11 22470365
12 22512475
13 22537095
14 22566922
15 12577288
16 32678907
17 32720856
18 62845553
19 22847871
20 12872424
21 12893843
22 12950307
23 22990210
01 4BICTEGRAVIR SODIUM | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
02 5DARUNAVIR ETHANOLATE | COBICISTAT | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
03 7ELVITEGRAVIR | COBICISTAT | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
04 6EMTRICITABINE | RILPIVIRINE HYDROCHLORIDE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
05 6EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
06 8Efavirenz | Emtricitabine | Tenofovir Disoproxil Fumarate
07 7Elvitegravir | Cobicistat | Emtricitabine | Tenofovir disoproxil fumarate
08 1Emtricitabine
09 3Emtricitabine | Tenofovir Disoproxil Fumarate
10 7tenofovir disoproxil fumarate | emtricitabine | rilpivirine
01 1Capsule
02 28TABLET
03 18Tablet
04 7Tablets
01 22011-01-31
02 22012-02-20
03 22012-03-05
04 12013-07-29
05 42017-07-25
06 12018-02-02
07 42018-07-23
08 12019-06-23
09 22021-02-26
10 62021-07-20
11 22022-08-09
12 22023-11-20
13 22024-01-13
14 22024-09-03
15 22025-05-19
16 12025-09-02
17 22026-12-29
18 32028-02-22
19 32029-05-01
20 62032-08-15
21 12033-12-19
22 12035-06-19
23 22036-06-29
Patent Expiration Date : 2011-01-31
Date Granted : 2004-11-30
Brand Name : EMTRIVA
Patent Number : 2075189
Filing Date : 1991-01-31
Strength per Unit : 200mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-01-31
Date Granted : 2004-11-30
Patent Expiration Date : 2024-01-13
Date Granted : 2009-06-02
Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : TRUVADA
Patent Number : 2512475
Filing Date : 2004-01-13
Strength per Unit : 200mg / 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-01-13
Date Granted : 2009-06-02
Patent Expiration Date : 2011-01-31
Date Granted : 2004-11-30
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2075189
Filing Date : 1991-01-31
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-01-31
Date Granted : 2004-11-30
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2261619
Filing Date : 1997-07-25
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Patent Expiration Date : 2013-07-29
Date Granted : 2001-08-28
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2101572
Filing Date : 1993-07-29
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-07-29
Date Granted : 2001-08-28
Patent Expiration Date : 2012-02-20
Date Granted : 2005-10-18
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2104399
Filing Date : 1992-02-20
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-02-20
Date Granted : 2005-10-18
Patent Expiration Date : 2012-03-05
Date Granted : 2003-10-28
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2105486
Filing Date : 1992-03-05
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-03-05
Date Granted : 2003-10-28
Patent Expiration Date : 2024-01-13
Date Granted : 2009-06-02
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2512475
Filing Date : 2004-01-13
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-01-13
Date Granted : 2009-06-02
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : TRUVADA
Patent Number : 2298059
Filing Date : 1998-07-23
Strength per Unit : 200mg / 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : TRUVADA
Patent Number : 2261619
Filing Date : 1997-07-25
Strength per Unit : 200mg / 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
